Barclays upgrades Hiscox, reinstates Frasers with divergent outlooks

Barclays upgraded Hiscox to "overweight" with a price target of GBp1,400, citing confidence in the company's Retail segment overhaul and projecting EPS growth of 8-22% between 2026 and 2028 driven by a new strategy targeting 5-15% top-line growth. Conversely, Barclays reinstated coverage of Frasers Group at "equal weight" with a price target of GBp760, noting the success of its "elevation strategy" but requiring further evidence of operational synergies before a potential re-rating.

Analysis

Barclays has upgraded Hiscox (LON:HSX) to “overweight” from “equal weight,” raising its price target by 19% to GBp1,400, based on renewed confidence in Hiscox’s Retail segment strategic overhaul. This overhaul is aimed at driving accelerated growth and improved profitability, with Barclays projecting an 8–22% increase in Hiscox’s EPS between 2026 and 2028. The new Retail strategy targets 5–15% top-line growth, an undiscounted combined ratio between 89–94%, and is anticipated to deliver a U.S.$200 million profit and loss benefit by 2028. Consequently, the Retail segment's contribution to Hiscox’s total pre-tax profit is expected to rise from 47% in 2024 to 60% by 2028. As of June 18, Hiscox shares traded at GBp1,274, indicating a 9.9% upside to Barclays' revised target. Conversely, Barclays reinstated coverage of Frasers Group at “equal weight,” maintaining its price target at GBp760. While Frasers Group’s “elevation strategy” has reportedly strengthened brand partnerships and product offerings, improving its standing with global suppliers, and the company maintains a strong U.K. retail presence alongside international expansion efforts, Barclays suggests that further evidence of operational synergies, particularly from its financial investments, is necessary to warrant a re-rating. Frasers shares were priced at GBp683 as of June 18, 2025, implying an 11.3% potential upside to Barclays' target, but the brokerage remains watchful for concrete performance improvements.

Key Decisions for Investors

• Investors might consider Hiscox more favorably following Barclays' upgrade and strong growth projections for its Retail segment, closely monitoring the execution of the new strategy and its impact on EPS and profitability towards the GBp1,400 price target.
• For Frasers Group, the "equal weight" rating and the requirement for further evidence of operational synergies suggest a cautious approach; investors should await tangible progress on these synergies and international expansion before anticipating a significant stock re-rating, despite the noted 11.3% upside to the GBp760 target.
• The contrasting ratings highlight different investment theses: Hiscox presents a growth story driven by a specific strategic overhaul, while Frasers Group's potential re-rating is contingent on demonstrating broader operational efficiencies and successful execution of its strategic initiatives.